← Back to companies
Aptimmune
0 open1 filled
St Louis, Missouri, United StatesFounded 20106+ employees$8.8M raisedPrivate
Last round: convertible note · Jan 2022(5 rounds total)
Founded by Federico Zuckermann, Heather Bessoff
Backed by(10 investors)
Kemin IndustriesCultivation CapitalThe Yield LabArsenal Capital PartnersThe Yield Lab Asia PacificMissouri Technology CorporationSt. Louis Arch AngelsArsenal Capital ManagementFox VenturesIllinois Ventures
Aptimmune Biologics specializes in developing revolutionary mucosal vaccines that provide unsurpassed efficacy against the viral diseases most costly to the swine industry. We focus on swine vaccines and the prevention of two major diseases – Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and influenza.
Open Positions at Aptimmune (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Aptimmune?
